Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6427
    +0.0001 (+0.02%)
     
  • OIL

    82.48
    -0.25 (-0.30%)
     
  • GOLD

    2,395.20
    -2.80 (-0.12%)
     
  • Bitcoin AUD

    100,990.48
    +3,763.02 (+3.87%)
     
  • CMC Crypto 200

    1,334.09
    +21.46 (+1.64%)
     
  • AUD/EUR

    0.6017
    -0.0014 (-0.23%)
     
  • AUD/NZD

    1.0887
    +0.0012 (+0.11%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,318.36
    -75.96 (-0.44%)
     
  • FTSE

    7,834.49
    -42.56 (-0.54%)
     
  • Dow Jones

    37,854.41
    +79.03 (+0.21%)
     
  • DAX

    17,717.72
    -119.68 (-0.67%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

2 Stocks Near 52-Week Highs That Could Climb Higher

2 Stocks Near 52-Week Highs That Could Climb Higher

Rising interest rates and a looming recession that those higher rates could cause are weighing heavily on stock prices across the board. Shares of Biogen (NASDAQ: BIIB) have been on a roller coaster over the past couple of years. The stock rocketed higher in 2021 after the FDA granted a highly controversial approval to the company's Alzheimer's disease drug, Aduhelm.